• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Sci-B-Vac
    / Scivac


    Active Ingredient
    Hepatitis B Vaccine 2.5 mcg/0.5 ml, 5 mcg/0.5 ml, 10 mcg/ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    1 X 10mcg/ml

    full basket chart 81014 19909

    Vial

    25 X 10mcg/ml

    full basket chart 81010 19906

    Vial

    1 X 2.5mcg/0.5ml

    full basket chart 81016 19911

    Vial

    25 X 2.5mcg/0.5ml

    full basket chart 81013 19908

    Vial

    1 X 5mcg/0.5ml

    full basket chart 81015 19910

    Vial

    25 X 5mcg/0.5ml

    full basket chart 81011 19907

    Related information


    Indications

    Active immunization against hepatitis B virus (HBV) infection.


    Contra-Indications

    Subjects with known hypersensitivity to any components of the vaccine or to subjects who developed symptoms suggestive of hypersensitivity after an injection with the vaccine. As with other vaccines, administration should be postponed in subjects suffering from acute severe illness. The presence of a minor infection, however, is not a contraindication for immunization.


    Special Precautions

    Due to the long incubation period for hepatitis B, it is possible for unrecognized infection to be present at the time of vaccination. Vaccination may not prevent hepatitis B in such individuals. The vaccine will not prevent infection caused by other agents such as hepatitis A, hepatitis C and hepatitis E or other pathogens known to infect the liver. Individuals with severe compromised cardiopulmonary status or others in whom a febrile or systemic reaction could pose a significant risk. Should under no circumstances be administered intravenously. Pregnancy and lactation: The vaccine should be given to a pregnant woman only if clearly needed. Caution should be exercised when the vaccine is administered to a nursing woman.


    Side Effects

    Generally well tolerated. No serious adverse reactions have been reported.


    Drug interactions

    See literature.


    Manufacturer
    Scivac Ltd, Israel
    Licence holder
    CLOSE